PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

African-Americans equally likely to benefit from erlotinib and other targeted lung cancer therapy

2010-09-29
(Press-News.org) DENVER — African-American patients with non-small cell lung cancer are just as likely to display an epidermal growth factor receptor (EGFR) mutation in tumors as Caucasians, which suggests they are as likely to benefit from targeted therapies such as erlotinib.

"This study has immediate implications for patient management. Patients with EGFR mutations have a much better prognosis and respond better to erlotinib than those who do not," said Ramsi Haddad, Ph.D., director of the Laboratory of Translational Oncogenomics at the Barbara Ann Karmanos Cancer Institute, and assistant professor at Wayne State University School of Medicine.

Haddad's study, which he presented at the Fourth AACR International Conference on Molecular Diagnostics in Cancer Therapeutic Development, also showed that African-Americans were more likely to have mutations on exon 19, rather than exon 21, which suggests they would be even more responsive to erlotinib.

Erlotinib, currently marketed as Tarceva by Genentech, has shown remarkable benefits in non-small cell lung cancer patients with EGFR mutations. Other therapies are in development and the genetic testing is clinically available.

Previous studies had suggested that African-Americans had lower rates of EGFR mutation, which researchers had offered as a possible explanation for their generally poorer prognosis.

However, Haddad's study was larger than previous reports. His research team observed 149 patients with non-small cell lung cancer (NSCLC), including 80 Caucasians and 69 African-Americans.

Using state-of-the-art technology that allowed for simultaneous detection of hundreds of oncogene mutations in clinical samples, they identified EGFR mutations in 20 of these patients, including 12 Caucasians and eight African-Americans. The difference was not statistically significant.

Moreover, 100 percent of the EGFR mutations in African-Americans were in exon 19, compared with only two-thirds of the mutations found in Caucasian patients.

"It is well-documented that the incidence of lung cancer is higher among African-Americans, particularly men, and that their survival is generally poorer compared to their white counterparts," said Haddad. "Our data suggest that African-Americans with NSCLC harbor mutations in EGFR at rates similar to whites. Thus, African ancestry should not be a factor when deciding whether to test a tumor for these mutations, as doing so could widen the disparity seen in survival. Physicians treating these patients may want to consider this new information in their treatment decisions."

###

Follow the AACR on Twitter: @AACR #AACR
Follow the AACR on Facebook: http://www.facebook.com/aacr.org

The mission of the American Association for Cancer Research is to prevent and cure cancer. Founded in 1907, the AACR is the world's oldest and largest professional organization dedicated to advancing cancer research. The membership includes 32,000 basic, translational and clinical researchers; health care professionals; and cancer survivors and advocates in the United States and more than 90 other countries. The AACR marshals the full spectrum of expertise from the cancer community to accelerate progress in the prevention, diagnosis and treatment of cancer through high-quality scientific and educational programs. It funds innovative, meritorious research grants, research fellowships and career development awards. The AACR Annual Meeting attracts more than 18,000 participants who share the latest discoveries and developments in the field. Special Conferences throughout the year present novel data across a wide variety of topics in cancer research, treatment and patient care. The AACR publishes six major peer-reviewed journals: Cancer Research; Clinical Cancer Research; Molecular Cancer Therapeutics; Molecular Cancer Research; Cancer Epidemiology, Biomarkers & Prevention; and Cancer Prevention Research. The AACR also publishes CR, a magazine for cancer survivors and their families, patient advocates, physicians and scientists, providing a forum for sharing essential, evidence-based information and perspectives on progress in cancer research, survivorship and advocacy.

END



ELSE PRESS RELEASES FROM THIS DATE:

Novel biomarker may predict response to new VEGF receptor inhibitor

2010-09-29
DENVER — Researchers believe there may be a way to predict, based on individual tumors, those patients that are more likely to respond to the investigational new drug tivozanib. This is possible, the researchers from AVEO Pharmaceuticals, Inc. said, because they have used a new way of creating animal tumor models that mimic tumor variation seen in human. Based on the results of these studies, they have found a single biomarker that may predict resistance to tivozanib, an oral, triple VEGF (vascular endothelial growth factor) receptor inhibitor. Tivozanib is in an ...

Nanotechnology brings personalized therapy 1 step closer to reality

2010-09-29
DENVER — A novel technology can make nanoscale protein measurements, which scientists can use in clinical trials to learn how drugs work. "We are making progress toward the goal of understanding how drugs work in different individuals," said Alice C. Fan, M.D., instructor in the division of oncology at Stanford University School of Medicine. "Using new technologies makes it possible to measure effects of therapeutic agents in tumor cells and different cell populations within our patients. Now that we can make these measurements, we are one step closer to being able to ...

Method to detect bladder cancer earlier is under development

2010-09-29
DENVER — Scientists may have discovered a way to diagnose bladder cancer at its earliest and, therefore, most treatable stages by measuring the presence or absence of microRNA using already available laboratory tests. "Measuring expressions of microRNA in bodily fluid represents a very promising tool with widespread implications for screening," said Liana Adam, M.D., Ph.D., assistant professor in urology at The University of Texas MD Anderson Cancer Center. Adam presented her findings at the Fourth AACR International Conference on Molecular Diagnostics in Cancer Therapeutic ...

c-Met may be a biomarker for metastatic hepatocellular carcinoma

2010-09-29
DENVER — Targeting c-Met may be a promising personalized treatment method for approximately 45 percent of patients with hepatocellular carcinoma (HCC) who have c-Met-positive tumors, according to study results presented at the Fourth AACR International Conference on Molecular Diagnostics in Cancer Therapeutic Development. HCC is the most common primary malignant tumor of the liver; c-Met is a receptor for hepatocyte growth factor that appears to drive liver cancer growth, invasion and metastasis. "Current therapies for HCC patients are 'one size fits all.' We propose ...

Cost-effectiveness of routine use of pooled nucleic acid amplification testing

2010-09-29
Detection of acute HIV infection (the stage of disease immediately after HIV acquisition but before HIV antibodies are detectable) with pooled nucleic acid amplification testing (that detects the presence of HIV genetic material in the blood before antibodies are detectable) is feasible but not cost-effective in all settings. Rather, pooled nucleic acid amplification testing after testing for antibodies with third-generation enzyme immunoassays (which can detect the first antibody to appear after infection) or rapid testing is only cost-effective when targeted to settings ...

Chest physiotherapy not effective in infants hospitalized with acute bronchiolitis

2010-09-29
In research published this week in PLoS Medicine, Vincent Gajdos and colleagues report the results of a randomized trial conducted among hospitalized infants with bronchiolitis. The researchers enrolled nearly 500 children aged 15 days to 2 years who were admitted to seven French hospitals for a first episode of acute bronchiolitis. Their results show that a physiotherapy technique (increased exhalation and assisted cough) commonly used in France does not reduce time to recovery in this population. The researchers conclude "Our results did not support the recommendation ...

19-million-year-old genomic fossils of hepatitis B-like viruses in songbirds

2010-09-29
Biologists from The University of Texas at Arlington have uncovered virus fragments from the same family of the modern Hepatitis B virus locked inside the genomes of songbirds such as the modern-day zebra finch. The article, publishing next week in the online, open access journal PLoS Biology, marks the first time that endogenous hepadnaviruses have been found in any organism. An endogenous virus is one that deposits itself or fragments of itself into the chromosome of an organism, allowing it to be passed from generation-to-generation. Previously, most of these known "fossilized" ...

TGen/Mayo Clinic/Arizona Cancer Center study finds gene associated with aggressive skin cancer

2010-09-29
PHOENIX, Ariz. — Sept. 28, 2010 — The loss of a gene known as INPP5A could predict the onset, and track the progression, of an aggressive type of skin cancer, according to a study published today by the Arizona Cancer Center, Mayo Clinic and the Translational Genomics Research Institute (TGen). Targeting INPP5A could provide physicians with better ways to prevent and treat cutaneous squamous cell carcinoma, or SCC, a skin cancer that often spreads to other parts of the body, according to a scientific paper published today in the journal Cancer Prevention Research. "Loss ...

What next for the 2009 H1N1 influenza pandemic?

2010-09-29
WASHINGTON, DC – September 28, 2010 -- Now that the H1N1 influenza pandemic is officially over, what will happen to the virus? In a perspective article published today in the online open-access journal mBio®, scientists from the National Institutes of Health delve into history and explore the fates of other pandemic influenza viruses in order to speculate on the future of the most recent pandemic virus. "While human influenza viruses have often surprised us, available evidence leads to the hope that the current pandemic virus will continue to cause low or moderate mortality ...

Sodium plays key role in tissue regeneration

Sodium plays key role in tissue regeneration
2010-09-29
MEDFORD/SOMERVILLE, Mass. – Sodium gets a bad rap for contributing to hypertension and cardiovascular disease. Now biologists at Tufts University's School of Arts and Sciences have discovered that sodium also plays a key role in initiating a regenerative response after severe injury. The Tufts scientists have found a way to regenerate injured spinal cord and muscle by using small molecule drugs to trigger an influx of sodium ions into injured cells. The approach breaks new ground in the field of biomedicine because it requires no gene therapy; can be administered after ...

LAST 30 PRESS RELEASES:

Childhood traumatic events and transgender identity are strongly associated with suicidal thoughts and behaviors in university students

UVA to test if MRI can reveal undetected brain injuries in soldiers

Mount Sinai Morningside unveils new, state-of-the-art facility for patients who need inpatient rehabilitation

BD² announces new funding opportunities focused on biology of bipolar disorder

“Want to, but can’t”: A new model to explain the gap in waste separation behavior

Highly sensitive, next-generation wearable pressure sensors inspired by cat whiskers

Breaking the code of sperm motion: Two proteins found to be vital for male fertility

UC Irvine poll: Californians support stricter tech regulations for children

Study finds critically endangered sharks being sold as food in U.S. grocery stores

Meat from critically endangered sharks is commonly sold under false labels in the US

‘Capture strategies’ are harming efforts to save our planet warns scientists

Misconceptions keep some cancer patient populations from benefitting from hormone therapy

Predicting the green glow of aurorae on the red planet

Giant DNA discovered hiding in your mouth

Children lose muscle during early cancer treatment — new ECU study warns of a hidden danger to recovery 

World-first koala chlamydia vaccine approved

Taking the pulse of digital health in Asia

Even healthy children can be severely affected by RSV

Keto diet linked to reduced depression symptoms in college students

Blood test identifies HPV-associated head and neck cancers up to 10 years before symptoms

Odds of dementia strongly linked to number of co-existing mental health disorders

Large social and economic inequalities persist among UK doctors

Research reveals how microplastics threaten Gulf of Mexico marine life

AI tool developed at Oxford helps astronomers find supernovae in a sky full of noise

Hungry star is eating its cosmic twin at rate never seen before

The Age of Feasting: Late Bronze Age networks developed through massive food festivals, with animals brought from far and wide

Study of breast cell changes in motherhood provides clues to breastfeeding difficulties

Seizure spread marks loss of consciousness

Carlos Collet, MD, Ph.D., joins CRF® as director, cardiovascular imaging, physiology and translational therapeutics

Beyond weight loss: How healthy eating cuts chronic pain

[Press-News.org] African-Americans equally likely to benefit from erlotinib and other targeted lung cancer therapy